Literature DB >> 11589691

The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.

P Cohen1.   

Abstract

The reversible phosphorylation of proteins regulates almost all aspects of cell life, while abnormal phosphorylation is a cause or consequence of many diseases. Mutations in particular protein kinases and phosphatases gives rise to a number of disorders and many naturally occurring toxins and pathogens exert their effects by altering the phosphorylation states of intracellular proteins. In this lecture, I present an overview of the progress that is being made in developing specific inhibitors of protein kinases for the treatment of cancer and chronic inflammatory diseases and describe how recent advances in our understanding of the specificity and regulation of one particular protein kinase (GSK3) may facilitate the development of drugs to treat diabetes that would not have the potential to be oncogenic. I also discuss the exploitation of specific protein kinase inhibitors for the study of cell signalling and make recommendations for their effective use in cell-based assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589691     DOI: 10.1046/j.0014-2956.2001.02473.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  173 in total

1.  Regulating the regulators. Conference on protein phosphorylation and protein phosphatases.

Authors:  Viktor Dombradi; Josef Krieglstein; Susanne Klumpp
Journal:  EMBO Rep       Date:  2002-02       Impact factor: 8.807

2.  Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Authors:  Xiang Li; Varsha Rao; Jin Jin; Bin Guan; Kenna L Anderes; Charles J Bieberich
Journal:  J Proteome Res       Date:  2012-06-18       Impact factor: 4.466

3.  Monitoring Cellular Phosphorylation Signaling Pathways into Chromatin and Down to the Gene Level.

Authors:  Yumiao Han; Zuo-Fei Yuan; Rosalynn C Molden; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2015-11-05       Impact factor: 5.911

Review 4.  Solution NMR Spectroscopy for the Study of Enzyme Allostery.

Authors:  George P Lisi; J Patrick Loria
Journal:  Chem Rev       Date:  2016-01-06       Impact factor: 60.622

Review 5.  GSK3beta: role in therapeutic landscape and development of modulators.

Authors:  S Phukan; V S Babu; A Kannoji; R Hariharan; V N Balaji
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

6.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

Review 7.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

8.  A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.

Authors:  Navasona Krishnan; Konstantis F Konidaris; Gilles Gasser; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

9.  A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor.

Authors:  Satyanarayana R Pondugula; Cynthia Brimer-Cline; Jing Wu; Erin G Schuetz; Rakesh K Tyagi; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

10.  Juxtamembrane localization of the protein phosphatase-1 inhibitor protein PHI-1 in smooth muscle cells.

Authors:  Nikolaos A Tountas; James W Mandell; Allen D Everett; David L Brautigan
Journal:  Histochem Cell Biol       Date:  2004-04-09       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.